Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER_GOV × Alginates × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

Capecitabine 24 Cisplatin 21 tislelizumab 20 apatinib 20 Gemcitabine 20 Oxaliplatin 19 Paclitaxel 18 Irinotecan 17 Carboplatin 16 Docetaxel 15 Bevacizumab 13 Fluorouracil 12 Drug Therapy 11 pembrolizumab 10 camrelizumab 10 Cyclophosphamide 10 Radiation 9 Vinorelbine 8 S 1 (combination) 8 Rituximab 7 Erlotinib Hydrochloride 7 Cetuximab 7 Leucovorin 6 Albumin-Bound Paclitaxel 6 toripalimab 5 pyrotinib 5 fludarabine 5 Nivolumab 5 Injections 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡